We have completed the required pre-clinical studies of NV-143 necessary to complete an Investigational New Drug (IND) application, which we plan to submit to the U.S. Food and Drug Administration (FDA) in July.
company has a huge pipelien do your dd
PRE-CLINICAL ONLY!!!Hmmmmmmmmmm long way to go!!!!BETTER LOCK IN PROFITS!!!